List details
Basic info
Status | Opinion Adopted |
---|---|
Submitter | Belgium |
Submitter email | Reach@health.fgov.be |
Regulatory programme |
|
ATP number and date | ATP18 - (16/02/2022), 23/11/2023 |
Link to ATP |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Hazard classes open for commenting | Acute toxicity Skin corrosion/irritation Serious eye damage/eye irritation Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — single exposure Specific target organ toxicity — repeated exposure |
Intention timeline
Date of intention | 2018-06-05 |
---|---|
Expected date of submission | 2018-09-28 |
Submitted for accordance check | 2018-10-01 |
Final submission date | 2019-02-14 |
Start of consultation | 2019-04-01 |
Deadline for commenting | 2019-05-31 |
Date of opinion | 2020-10-08 |
Legal deadline for opinion adoption | 2020-08-15 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
RAC opinion |
|
Background document |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
This version
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
Feb. 4, 2021
- Background document: https://echa.europa.eu/documents/10162/8d4072da-fdf0-5128-424c-3c4234a893aa
- Comments received: https://echa.europa.eu/documents/10162/2fc925d3-d4e3-d6d4-95f1-e8784eb897b2 → https://echa.europa.eu/documents/10162/305c0048-21a4-e4ab-fb43-5ed5531ce11d
- RAC opinion: https://echa.europa.eu/documents/10162/3efea59e-2eee-fe7a-4160-868cf75042ac
Dec. 14, 2020
- Status: Opinion Development → Opinion Adopted
Oct. 29, 2020
- Date of opinion: 2020-10-08
March 16, 2020
- Submitter email: Reach@health.fgov.be
July 5, 2019
- Status: Public Consultation → Opinion Development
June 18, 2019
- Comments received: https://echa.europa.eu/documents/10162/2fc925d3-d4e3-d6d4-95f1-e8784eb897b2
April 4, 2019
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1b031443-d86b-578b-9293-dcd638a67263
- CLH report: https://echa.europa.eu/documents/10162/4213fdf4-8a7a-9468-4c58-b5aef9cad6fe
- Deadline for commenting: 2019-05-31
- Final submission date: 2019-02-14
- Hazard classes open for commenting: Acute toxicity Skin corrosion/irritation Serious eye damage/eye irritation Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — single exposure Specific target organ toxicity — repeated exposure
- Legal deadline for opinion adoption: 2020-08-15
- Proposed harmonised classification by the dossier submitter: Repr. 2, H361d
- Regulatory programme: Other substance → Chemical registered under REACH
- Status: Submitted → Public Consultation
- Start of consultation: 2019-04-01
- Submitter email: Reach@environment.belgium.be
Dec. 11, 2018
- Remarks: The substance is also under substance evaluation
Oct. 23, 2018
- Submitter: Belgium
- Submitter email: Reach@environment.belgium.be
Oct. 16, 2018
- Status: Intention → Submitted
- Submitter: Belgium
- Submitter email: Reach@environment.belgium.be
- Submitted for accordance check: 2018-10-01
Add the related substance to your watchlist to monitor this regulatory record.